author-photo

Monika M. Kutyna

University of Adelaide

16

Papers

29

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (6)
T-MDS Is a Distinct Clinical and Pathological Entity Characterized By Better Survival Compared to t-AML

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Burden of Cardiovascular Events and Bleeding Is High in Myelodysplastic Syndromes

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Therapy-Related Myeloid Neoplasm Has a Distinct Pro-Inflammatory Bone Marrow Microenvironment and Delayed DNA Damage Repair

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
FRI0016 MUTATIONAL LANDSCAPE OF MYELODYSPLASTIC SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATOLOGICAL DISORDERS

2019 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
3170 – ABERRANT BONE MARROW MICROENVIRONMENT IN THERAPY RELATED MYELOID NEOPLASM

2019 Experimental Hematology
Show All
- Source
- Cite
- Save
Citations (0)
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

2019 Leukemia
Show All
- Source
- Cite
- Save
Citations (15)
Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (6)
Deleterious Germline Variants, Especially in the DNA Repair Pathway, Are Common in Patients with Non-Related Multiple Cancers, One of Them Being Hematological Malignancy

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Red Cell Alloimmunisation Is Associated with Increased Red Cell Transfusion Requirements in Myelodysplastic Syndrome

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)